January 28, 2026 About this event
The drug reimbursement review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs.
Join us at a webinar on January 28, 2026, where members of our team will describe upcoming procedural changes and proposed improvements that we aim to introduce to continue modernizing drug reimbursement reviews.
We anticipate that these changes will help us streamline our work, bring greater predictability to our process, facilitate patient access to proven new drugs, and contribute to sustaining Canada’s position as a competitive market for introducing new treatments.
This webinar is a preconsultation event for all parties with an interest in drug reimbursement reviews.
Speakers:
- Peter Dyrda, Director, Pharmaceutical Reviews
- Laura Weeks, Director, Health Technology Assessment
- Michelle Gibbens, Director, Engagement
- Sam Sutherland, Engagement Officer (Moderator)